Skip to main content
Top
Published in: Strahlentherapie und Onkologie 12/2014

Open Access 01-11-2014 | Original article

Radiation-induced VEGF-C expression and endothelial cell proliferation in lung cancer

Authors: Yu-Hsuan Chen, MD, Shiow-Lin Pan, PhD, Jing-Chi Wang, BS, Sung-Hsin Kuo, MD, PhD, Jason Chia-Hsien Cheng, MD, PhD, Che-Ming Teng, PhD

Published in: Strahlentherapie und Onkologie | Issue 12/2014

Login to get access

Abstract

Background

The present study was undertaken to investigate whether radiation induces the expression of vascular endothelial growth factor C (VEGF-C) through activation of the PI3K/Akt/mTOR pathway,subsequently affecting endothelial cells.

Materials and methods

Radiotherapy-induced tumor micro-lymphatic vessel density (MLVD) was determined in a lung cancer xenograft model established in SCID mice. The protein expression and phosphorylation of members of the PI3K/Akt/mTOR pathway and VEGF-C secretion and mRNA expression in irradiated lung cancer cells were assessed by Western blot analysis, enzyme-linked immunosorbent assays (ELISAs), and reverse transcriptase–polymerase chain reaction (RT-PCR). Moreover, specific chemical inhibitors were used to evaluate the role of the PI3K/Akt/mTOR signaling pathway. Conditioned medium (CM) from irradiated control-siRNA or VEGF-C-siRNA-expressing A549 cells was used to evaluate the proliferation of endothelial cells by the MTT assay.

Results

Radiation increased VEGF-C expression in a dose-dependent manner over time at the protein but not at the mRNA level. Radiation also up-regulated the phosphorylation of Akt, mTOR, 4EBP, and eIF4E, but not of p70S6K. Radiation-induced VEGF-C expression was down-regulated by LY294002 and rapamycin (both p < 0.05). Furthermore, CM from irradiated A549 cells enhanced human umbilical vein endothelial cell (HUVEC) and lymphatic endothelial cell (LEC) proliferation, which was not observed with CM from irradiated VEGF-C-siRNA-expressing A549 cells.

Conclusions

Radiation-induced activation of the PI3K/Akt/mTOR signaling pathway increases VEGF-C expression in lung cancer cells, thereby promoting endothelial cell proliferation.
Literature
1.
go back to reference Mountain CF (1997) Revisions in the international system for staging lung cancer. Chest 111:1710–1717PubMedCrossRef Mountain CF (1997) Revisions in the international system for staging lung cancer. Chest 111:1710–1717PubMedCrossRef
2.
go back to reference Auperin A, Le Pechoux C, Pignon JP et al (2006) Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patients. Ann Oncol 17:473–483PubMedCrossRef Auperin A, Le Pechoux C, Pignon JP et al (2006) Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patients. Ann Oncol 17:473–483PubMedCrossRef
3.
go back to reference Penland SK, Socinski MA (2004) Management of unresectable stage III non-small cell lung cancer: the role of combined chemoradiation. Semin Radiat Oncol 14:326–334PubMedCrossRef Penland SK, Socinski MA (2004) Management of unresectable stage III non-small cell lung cancer: the role of combined chemoradiation. Semin Radiat Oncol 14:326–334PubMedCrossRef
4.
go back to reference Perez CA, Bauer M, Edelstein S et al (1986) Impact of tumor control on survival in carcinoma of the lung treated with irradiation. Int J Radiat Oncol Biol Phys 12:539–547PubMedCrossRef Perez CA, Bauer M, Edelstein S et al (1986) Impact of tumor control on survival in carcinoma of the lung treated with irradiation. Int J Radiat Oncol Biol Phys 12:539–547PubMedCrossRef
5.
go back to reference Jeltsch M, Kaipainen A, Joukov V et al (1997) Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276:1423–1425PubMedCrossRef Jeltsch M, Kaipainen A, Joukov V et al (1997) Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276:1423–1425PubMedCrossRef
6.
go back to reference Lymboussaki A, Achen MG, Stacker SA et al (2000) Growth factors regulating lymphatic vessels. Curr Top Microbiol Immunol 251:75–82PubMed Lymboussaki A, Achen MG, Stacker SA et al (2000) Growth factors regulating lymphatic vessels. Curr Top Microbiol Immunol 251:75–82PubMed
7.
go back to reference Saaristo A, Veikkola T, Enholm B et al (2002) Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes. FASEB J 16:1041–1049PubMedCrossRef Saaristo A, Veikkola T, Enholm B et al (2002) Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes. FASEB J 16:1041–1049PubMedCrossRef
8.
go back to reference Arinaga M, Noguchi T, Takeno S et al (2003) Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma. Cancer 97:457–464PubMedCrossRef Arinaga M, Noguchi T, Takeno S et al (2003) Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma. Cancer 97:457–464PubMedCrossRef
9.
go back to reference Kajita T, Ohta Y, Kimura K et al (2001) The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer. Br J Cancer 85:255–260PubMedCentralPubMedCrossRef Kajita T, Ohta Y, Kimura K et al (2001) The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer. Br J Cancer 85:255–260PubMedCentralPubMedCrossRef
10.
go back to reference Saintigny P, Kambouchner M, Ly M et al (2007) Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node. Lung Cancer 58:205–213PubMedCrossRef Saintigny P, Kambouchner M, Ly M et al (2007) Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node. Lung Cancer 58:205–213PubMedCrossRef
12.
go back to reference Nathanson SD, Westrick P, Anaya P et al (1989) Relationship of spontaneous regional lymph node metastases to dose of local irradiation of primary B16 melanomas. Cancer Res 49:4412–4416PubMed Nathanson SD, Westrick P, Anaya P et al (1989) Relationship of spontaneous regional lymph node metastases to dose of local irradiation of primary B16 melanomas. Cancer Res 49:4412–4416PubMed
13.
go back to reference Talmadge JE, Wolman SR, Fidler IJ (1982) Evidence for the clonal origin of spontaneous metastases. Science 217:361–363PubMedCrossRef Talmadge JE, Wolman SR, Fidler IJ (1982) Evidence for the clonal origin of spontaneous metastases. Science 217:361–363PubMedCrossRef
14.
go back to reference Heisel MA, Laug WE, Stowe SM et al (1984) Effects of X-irradiation on artificial blood vessel wall degradation by invasive tumor cells. Cancer Res 44:2441–2445PubMed Heisel MA, Laug WE, Stowe SM et al (1984) Effects of X-irradiation on artificial blood vessel wall degradation by invasive tumor cells. Cancer Res 44:2441–2445PubMed
15.
go back to reference Cheng JC, Chou CH, Kuo ML et al (2006) Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway. Oncogene 25:7009–7018PubMedCrossRef Cheng JC, Chou CH, Kuo ML et al (2006) Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway. Oncogene 25:7009–7018PubMedCrossRef
16.
17.
18.
go back to reference Petrova TV, Makinen T, Makela TP et al (2002) Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J 21:4593–4599PubMedCentralPubMedCrossRef Petrova TV, Makinen T, Makela TP et al (2002) Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J 21:4593–4599PubMedCentralPubMedCrossRef
19.
go back to reference Shibuya K, Komaki R, Shintani T et al (2007) Targeted therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in an orthotopic model of human non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 69:1534–1543PubMedCentralPubMedCrossRef Shibuya K, Komaki R, Shintani T et al (2007) Targeted therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in an orthotopic model of human non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 69:1534–1543PubMedCentralPubMedCrossRef
20.
go back to reference Sonveaux P, Brouet A, Havaux X et al (2003) Irradiation-induced angiogenesis through the up-regulation of the nitric oxide pathway: implications for tumor radiotherapy. Cancer Res 63:1012–1019PubMed Sonveaux P, Brouet A, Havaux X et al (2003) Irradiation-induced angiogenesis through the up-regulation of the nitric oxide pathway: implications for tumor radiotherapy. Cancer Res 63:1012–1019PubMed
21.
go back to reference Nozue M, Isaka N, Fukao K (2001) Over-expression of vascular endothelial growth factor after preoperative radiation therapy for rectal cancer. Oncol Rep 8:1247–1249PubMed Nozue M, Isaka N, Fukao K (2001) Over-expression of vascular endothelial growth factor after preoperative radiation therapy for rectal cancer. Oncol Rep 8:1247–1249PubMed
22.
go back to reference Dent P, Yacoub A, Contessa J et al (2003) Stress and radiation-induced activation of multiple intracellular signaling pathways. Radiat Res 159:283–300PubMedCrossRef Dent P, Yacoub A, Contessa J et al (2003) Stress and radiation-induced activation of multiple intracellular signaling pathways. Radiat Res 159:283–300PubMedCrossRef
23.
go back to reference Cordes N, Rödel F, Rodemann HP (2012) Molecular signaling pathways. mechanisms and clinical use. Strahlenther Onkol 188:308–311PubMedCrossRef Cordes N, Rödel F, Rodemann HP (2012) Molecular signaling pathways. mechanisms and clinical use. Strahlenther Onkol 188:308–311PubMedCrossRef
24.
go back to reference Massion PP, Taflan PM, Shyr Y et al (2004) Early involvement of the phosphatidylinositol 3-kinase/Akt pathway in lung cancer progression. Am J Respir Crit Care Med 170:1088–1094PubMedCrossRef Massion PP, Taflan PM, Shyr Y et al (2004) Early involvement of the phosphatidylinositol 3-kinase/Akt pathway in lung cancer progression. Am J Respir Crit Care Med 170:1088–1094PubMedCrossRef
25.
go back to reference Kobayashi M, Nagata S, Iwasaki T et al (1999) Dedifferentiation of adenocarcinomas by activation of phosphatidylinositol 3-kinase. Proc Natl Acad Sci U S A 96:4874–4879PubMedCentralPubMedCrossRef Kobayashi M, Nagata S, Iwasaki T et al (1999) Dedifferentiation of adenocarcinomas by activation of phosphatidylinositol 3-kinase. Proc Natl Acad Sci U S A 96:4874–4879PubMedCentralPubMedCrossRef
26.
go back to reference Sunavala-Dossabhoy G, Fowler M, De Benedetti A (2004) Translation of the radioresistance kinase TLK1B is induced by gamma-irradiation through activation of mTOR and phosphorylation of 4E-BP1. BMC Mol Biol 5:1–10PubMedCentralPubMedCrossRef Sunavala-Dossabhoy G, Fowler M, De Benedetti A (2004) Translation of the radioresistance kinase TLK1B is induced by gamma-irradiation through activation of mTOR and phosphorylation of 4E-BP1. BMC Mol Biol 5:1–10PubMedCentralPubMedCrossRef
27.
go back to reference Albert JM, Kim KW, Cao C et al (2006) Targeting the Akt/mammalian target of rapamycin pathway for radiosensitization of breast cancer. Mol Cancer Ther 5:1183–1189PubMedCrossRef Albert JM, Kim KW, Cao C et al (2006) Targeting the Akt/mammalian target of rapamycin pathway for radiosensitization of breast cancer. Mol Cancer Ther 5:1183–1189PubMedCrossRef
28.
go back to reference Dionysopoulos D, Pavlakis K, Kotoula V et al (2013) Cyclin D1, EGFR, and Akt/mTOR pathway. Potential prognostic markers in localized laryngeal squamous cell carcinoma. Strahlenther Onkol 189:202–214PubMedCrossRef Dionysopoulos D, Pavlakis K, Kotoula V et al (2013) Cyclin D1, EGFR, and Akt/mTOR pathway. Potential prognostic markers in localized laryngeal squamous cell carcinoma. Strahlenther Onkol 189:202–214PubMedCrossRef
29.
go back to reference Kobayashi S, Kishimoto T, Kamata S et al (2007) Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis. Cancer Sci 98:726–733PubMedCrossRef Kobayashi S, Kishimoto T, Kamata S et al (2007) Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis. Cancer Sci 98:726–733PubMedCrossRef
30.
go back to reference Tang Y, Zhang D, Fallavollita L, Brodt P (2003) Vascular endothelial growth factor C expression and lymph node metastasis are regulated by the type I insulin like growth factor receptor. Cancer Res 63:1166–1171PubMed Tang Y, Zhang D, Fallavollita L, Brodt P (2003) Vascular endothelial growth factor C expression and lymph node metastasis are regulated by the type I insulin like growth factor receptor. Cancer Res 63:1166–1171PubMed
31.
go back to reference Morfoisse F, Kuchnio A, Frainay CH et al (2014) Hypoxia induces VEGF-C expression in metastatic tumor cells via a HIF-1α-Independent translation-mediated mechanism. Cell Rep 6:155–167PubMedCrossRef Morfoisse F, Kuchnio A, Frainay CH et al (2014) Hypoxia induces VEGF-C expression in metastatic tumor cells via a HIF-1α-Independent translation-mediated mechanism. Cell Rep 6:155–167PubMedCrossRef
Metadata
Title
Radiation-induced VEGF-C expression and endothelial cell proliferation in lung cancer
Authors
Yu-Hsuan Chen, MD
Shiow-Lin Pan, PhD
Jing-Chi Wang, BS
Sung-Hsin Kuo, MD, PhD
Jason Chia-Hsien Cheng, MD, PhD
Che-Ming Teng, PhD
Publication date
01-11-2014
Publisher
Springer Berlin Heidelberg
Published in
Strahlentherapie und Onkologie / Issue 12/2014
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-014-0708-z

Other articles of this Issue 12/2014

Strahlentherapie und Onkologie 12/2014 Go to the issue

MITTEILUNGEN DER FACHGESELLSCHAFTEN

Mitteilungen der Fachgesellschaften